Lebwohl, M., H. . Bachelez, K. Gordon, T. Wu, M. Chen, B. Kaplan, and K. Papp. “Maintenance of Clinical Response With Continued Risankizumab Treatment for Moderate-to-Severe Psoriasis Through 304 Weeks: Interim Analysis of the LIMMitless Open-Label Extension Study”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s258, doi:10.25251/skin.7.supp.258.